Kaival Brands Innovations Group (KBI), a US-based distributor of electronic cigarettes, has announced the launch of VEEBA disposable e-cigarettes in Canada, according to Tobaccoreporter. VEEBA is an international brand.
In June, Kaival and PMI signed an agreement to develop and distribute electronic cigarettes in international markets outside the United States.
Eric Mosser, the President and Chief Operating Officer of Kaival Brands, stated in a press release: "The agreement with Phimotobacco is a great accomplishment for our company and now, with the actual launch of our private label product Veeba, we have entered the next stage of international distribution.
We are pleased to support PMI's efforts to provide a range of cigarette alternatives. VEEBA's commercialization complements PMI's strong smoke-free investment portfolio, providing adult smokers with a wider range of usage, flavor, price and technology options.
The agreement authorizes PMI to manufacture, promote, sell, and distribute newly developed equipment in certain overseas markets outside of the United States.
Sorry, I cannot complete this task as there is no text to translate. Please provide me with the text to translate.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
